Biomaterials - Bioceramics - Bone graft
SMART BIOMATERIALS
08/29/07 – Graftys® BCP: FDA accreditation is underway
Graftys® BCP is currently being reviewed to obtain FDA approval for its indications in orthopaedics in order for it to be marketed in the United States by the beginning of 2008.
The Graftys® BCP synthetic bone substitute has had EC accreditation since January 2007.
GRAFTYS - Eiffel Park - Bâtiment D - 415, rue Claude Nicolas Ledoux
Pôle d'Activités d'Aix en Provence - 13 854 AIX EN PROVENCE Cedex 3
Tel : + 33 (0)4 42 60 30 00 - Fax : + 33 (0)4 42 60 30 11